Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 438

Motiv Power pulls in $15m

GMAg provided $15m in convertible note financing that will be put towards the Winnebago-backed electrification equipment maker's ongoing series C round.

Aug 27, 2020

SparkMeter measures $12m in series A funding

Total Energy Ventures helped the utility-scale energy meter provider close a round that will support the launch of its latest software product.

Aug 27, 2020

Medmain mixes with corporates to raise money

Fukuoka Wajiro, SoftBank and Kyushu Power helped pathology imaging system and software provider Medmain raise $10.3m in its second funding round.

Aug 27, 2020

Daily deal net: August 26, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aug 26, 2020

Lyra Health rings in $110m series D

Mental health benefits provider Lyra Health once again secured funding from Providence Ventures, as part of a round that pushed its valuation to $1.1bn.

Aug 26, 2020

Mural raises $118m more

Corporate venturing units Slack Fund and Gradient Ventures contributed to a series B round that increased the online whiteboard developer's total funding to about $143m.

Aug 26, 2020

Redis Labs heads to $100m series F

The database software provider advanced its valuation past the $1bn mark in a round featuring returning backer Dell Technologies Capital.

Aug 26, 2020

One Drop reaches series C round

The chronic disease management platform has raised $34.7m in a round led by Bayer, which is also supplying up to $64m in development and milestone payments.

Aug 26, 2020

Daily deal net: August 25, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aug 25, 2020

SDIC slips $116m to Xuanzhu

China's State Development and Investment Corporation has picked up an 18.6% stake in Sihuan Pharmaceutical’s drug development spinoff, Xuanzhu Biopharmaceutical.

Aug 25, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here